150 related articles for article (PubMed ID: 12829326)
1. Region-specific changes in NMDA receptor mRNA induced by chronic morphine treatment are prevented by the co-administration of the competitive NMDA receptor antagonist LY274614.
Zhu H; Brodsky M; Gorman AL; Inturrisi CE
Brain Res Mol Brain Res; 2003 Jun; 114(2):154-62. PubMed ID: 12829326
[TBL] [Abstract][Full Text] [Related]
2. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
[TBL] [Abstract][Full Text] [Related]
3. Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist, LY274614.
Tiseo PJ; Inturrisi CE
J Pharmacol Exp Ther; 1993 Mar; 264(3):1090-6. PubMed ID: 8450453
[TBL] [Abstract][Full Text] [Related]
4. CNS levels of mu opioid receptor (MOR-1) mRNA during chronic treatment with morphine or naltrexone.
Brodsky M; Elliott K; Hynansky A; Inturrisi CE
Brain Res Bull; 1995; 38(2):135-41. PubMed ID: 7583338
[TBL] [Abstract][Full Text] [Related]
5. Effects of NMDA receptor antagonists on morphine tolerance: a c-Fos study in the lumbar spinal cord of the rat.
Le Guen S; Catheline G; Besson JM
Eur J Pharmacol; 1999 May; 373(1):1-11. PubMed ID: 10408246
[TBL] [Abstract][Full Text] [Related]
6. Modulation of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist LY274614: assessment of opioid receptor changes.
Tiseo PJ; Cheng J; Pasternak GW; Inturrisi CE
J Pharmacol Exp Ther; 1994 Jan; 268(1):195-201. PubMed ID: 8301558
[TBL] [Abstract][Full Text] [Related]
7. Intracerebroventricular administration of NMDA-R1 antisense oligodeoxynucleotide significantly alters the activity of ventral tegmental area dopamine neurons: an electrophysiological study.
Tajiri K; Emori K; Murata M; Tanaka K; Suzuki M; Uehara T; Sumiyoshi T; Ashby CR; Kurachi M
Synapse; 2001 Jun; 40(4):275-81. PubMed ID: 11309843
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of Group I metabotropic glutamate receptors antagonists on the expression of NMDA receptor NR1 subunit in morphine tolerant rats.
Liu JB; Yao YX; Jiang W
Neurosci Lett; 2009 Mar; 452(3):268-72. PubMed ID: 19348736
[TBL] [Abstract][Full Text] [Related]
9. Dizocilpine infusion has a different effect in the development of morphine and cocaine sensitization: behavioral and neurochemical aspects.
Scheggi S; Mangiavacchi S; Masi F; Gambarana C; Tagliamonte A; De Montis MG
Neuroscience; 2002; 109(2):267-74. PubMed ID: 11801363
[TBL] [Abstract][Full Text] [Related]
10. Modulation of the levels of NMDA receptor subunit mRNA and the bindings of [3H]MK-801 in rat brain by chronic infusion of subtoxic dose of MK-801.
Oh S; Kim YH; Hann HJ; Lee HL; Choi HS; Kim HS; Ho IK
Neurochem Res; 2001 May; 26(5):559-65. PubMed ID: 11513485
[TBL] [Abstract][Full Text] [Related]
11. Amitriptyline attenuates astrocyte activation and morphine tolerance in rats: role of the PSD-95/NR1/nNOS/PKCĪ³ signaling pathway.
Huang YN; Tsai RY; Lin SL; Chien CC; Cherng CH; Wu CT; Yeh CC; Wong CS
Behav Brain Res; 2012 Apr; 229(2):401-11. PubMed ID: 22309983
[TBL] [Abstract][Full Text] [Related]
12. The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids.
Elliott K; Minami N; Kolesnikov YA; Pasternak GW; Inturrisi CE
Pain; 1994 Jan; 56(1):69-75. PubMed ID: 7512709
[TBL] [Abstract][Full Text] [Related]
13. Involvement of glutamatergic receptors in the nucleus cuneiformis in modulating morphine-induced antinociception in rats.
Haghparast A; Gheitasi IP; Lashgari R
Eur J Pain; 2007 Nov; 11(8):855-62. PubMed ID: 17291798
[TBL] [Abstract][Full Text] [Related]
14. An antisense oligonucleotide to the N-methyl-D-aspartate (NMDA) subunit NMDAR1 attenuates NMDA-induced nociception, hyperalgesia, and morphine tolerance.
Shimoyama N; Shimoyama M; Davis AM; Monaghan DT; Inturrisi CE
J Pharmacol Exp Ther; 2005 Feb; 312(2):834-40. PubMed ID: 15388787
[TBL] [Abstract][Full Text] [Related]
15. NMDA antagonists and clonidine block c-fos expression during morphine withdrawal.
Rasmussen K; Brodsky M; Inturrisi CE
Synapse; 1995 May; 20(1):68-74. PubMed ID: 7624831
[TBL] [Abstract][Full Text] [Related]
16. Morphine tolerance increases [3H]MK-801 binding affinity and constitutive neuronal nitric oxide synthase expression in rat spinal cord.
Wong CS; Hsu MM; Chou YY; Tao PL; Tung CS
Br J Anaesth; 2000 Oct; 85(4):587-91. PubMed ID: 11064618
[TBL] [Abstract][Full Text] [Related]
17. Melatonin prevents morphine-induced hyperalgesia and tolerance in rats: role of protein kinase C and N-methyl-D-aspartate receptors.
Song L; Wu C; Zuo Y
BMC Anesthesiol; 2015; 15():12. PubMed ID: 25745356
[TBL] [Abstract][Full Text] [Related]
18. Modulation of morphine analgesia by site-specific N-methyl-D-aspartate receptor antagonists: dependence on sex, site of antagonism, morphine dose, and time.
Nemmani KVS; Grisel JE; Stowe JR; Smith-Carliss R; Mogil JS
Pain; 2004 Jun; 109(3):274-283. PubMed ID: 15157688
[TBL] [Abstract][Full Text] [Related]
19. Effects of N-methyl-D-aspartate receptor antagonists on acute morphine-induced and l-methadone-induced antinociception in mice.
Fischer BD; Carrigan KA; Dykstra LA
J Pain; 2005 Jul; 6(7):425-33. PubMed ID: 15993820
[TBL] [Abstract][Full Text] [Related]
20. Effects of LY274614, a competitive NMDA receptor antagonist, on the micturition reflex in the urethane-anaesthetized rat.
Yoshiyama M; Roppolo JR; Thor KB; de Groat WC
Br J Pharmacol; 1993 Sep; 110(1):77-86. PubMed ID: 8106110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
